Nephroblastoma Treatment and Outcomes in a Low-Income Setting.
Cyprien ShyirambereChandler VillaverdeCam NguyenDeogratias RuhangazaAline UmwizerwaOscar NsanzimanaLouis MujyuwishaEsperance IradukundaLawrence N ShulmanLeslie LehmannPublished in: JCO global oncology (2022)
We demonstrate that patients with nephroblastoma can be successfully treated in a low-resource setting. Survival remains lower than in high-income countries, in part due to early deaths, contributing to approximately 30% of patients not being medically able to receive surgical intervention. Next steps include the development of strategies that focus on earlier diagnosis, supportive care during the early phases of therapy, and efficient and timely transitions between specialties for multimodal care.
Keyphrases
- healthcare
- end stage renal disease
- palliative care
- pain management
- ejection fraction
- quality improvement
- randomized controlled trial
- chronic kidney disease
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- mental health
- type diabetes
- physical activity
- affordable care act
- stem cells
- metabolic syndrome
- skeletal muscle
- replacement therapy
- weight loss